No Borders (OTC: NBDR) today announced that it has
amended its existing SEC Qualified Reg A offering to dramatically cut the
number of authorized shares available from 300,000,000 to 100,000,000 while
increasing the offering price per share from $0.01 per share to $0.03 per
share, effective immediately. This amendment keeps the total amount of capital
available to be raised by the company at $3,000,000 but vastly lowers the total
possible dilution of the common stock. “If you take the time to watch the last
three or four NBDR Shareholder Update Videos that are on our YouTube Channel you
will see that we have stated over and over our commitment to NOT issuing 300
million new shares into the market. Our executive team and I are major common
stock shareholders of NBDR and as such are just as sensitive to dilution as any
shareholder in the company. This amendment is another example of why we are
#DifferentByDesign and clearly shows that the action steps we are taking are
designed to improve shareholder value and minimize dilution while providing our
businesses with the capital they need to deploy and scale,” No Borders CEO
Joseph Snyder stated in the news release.
To view the full press release, visit http://ibn.fm/YweK7
About No Borders Inc.
No Borders, Inc. (OTC: NBDR) is a multifaceted corporation
specializing in the acquisition, creation, and scaling of commercial and
consumer products by utilizing cutting-edge technologies to reduce costs while
increasing revenues and shareholder value through technological superiority and
Intellectual Property ownership across its portfolio of assets. The Company’s
portfolio of brands includes:
- No
Borders Naturals Inc., a purveyor of health and wellness products for
active consumers and their pets (NoBordersNaturals.com).
- No
Borders Labs Inc., which provides leading-edge tech tools to NBDR internal
companies while also offering consulting, architecture and software
development services to external businesses looking to update their
technology infrastructure for greater efficiency, security, and
transparency (NoBordersLabs.com).
- CBDLabChain.com a
powerful, Patent Pending tool to demonstrate in an unbiased and unchangeable
way a clear sense of security to consumers of CBD products by recording
Certificate of Authority (COA) on a blockchain technology platform.
- No
Borders Dental Resources Inc., a provider of equipment and supplies to
medical and dental professionals across the U.S. through the trade name
MediDent Supplies (MediDentSupplies.com).
No Borders is headquartered in Arizona with resources in the
U.S., South America, Asia, and Europe. For more information, visit the
Company’s website at www.NBDR.co.
NOTE TO INVESTORS: The latest news and updates
relating to NBDR are available in the company’s newsroom at http://ibn.fm/NBDR
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and more,
these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment